-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Kyverna Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2023 to Q3 2024.
- Kyverna Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $339M.